Clinical trials recruiting in Huaihua, China

Phase breakdown

Conditions recruiting in Huaihua, China

Recruiting trials in Huaihua, China

• China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
  NCT04974138 · Phase: Phase 4 · Ages: 45 Years to 74 Years · Sex: All (male and female)
• China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
  NCT04974151 · Phase: Phase 4 · Ages: 45 Years to 74 Years · Sex: All (male and female)
• Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
  NCT07796516 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Huaihua, China?

3 recruiting trials have at least one study site in Huaihua, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.